<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9110">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05705050</url>
  </required_header>
  <id_info>
    <org_study_id>36264PR19/1/23</org_study_id>
    <nct_id>NCT05705050</nct_id>
  </id_info>
  <brief_title>Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy</brief_title>
  <official_title>Effect of Intraoperative Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to evaluate the effect of intraoperative systemic aminophylline&#xD;
      infusion on pain intensity in patients undergoing ureteroscopic lithotripsy surgeries with&#xD;
      ureteric stent placement at the end of the procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2023</start_date>
  <completion_date type="Anticipated">June 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensity of pain</measure>
    <time_frame>In post anesthesia care unit (PACU)</time_frame>
    <description>Visual analogue score (VAS) score: will be measured on arrival to PACU, at 30 minutes, 1 hour, 2 hour, 6, 12 and 24 hour after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensity of pain</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>Visual analogue score (VAS) score: will be measured on arrival to PACU, at 30 minutes, 1 hour, 2 hour, 6, 12 and 24 hour after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of opioid dose</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>If Patients reported VAS score more than 3, they will receive intravenous 0.5 mg /kg pethidine. All patients will be observed in PACU for at least 2 hour and in the ward on the day of surgery for confirming any side effects or complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of postoperative adverse reactions</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>the incidence of adverse reactions, such as arrhythmia, postoperative nausea and vomiting (PONV) and postoperative lightheadedness will be recorded in both groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Aminophylline</condition>
  <condition>Pain</condition>
  <condition>Ureterocopic Lithotripsy</condition>
  <arm_group>
    <arm_group_label>Aminophylline group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 4 mg/kg aminophylline diluted in 100 ml normal saline over 20 minutes after induction of anesthesia and positioning of patients in lithotomy position.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive 100 ml normal saline over 20 minutes after induction and lithotomy positioning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aminophylline group</intervention_name>
    <description>Patients will receive 4 mg/kg aminophylline diluted in 100 ml normal saline over 20 minutes after induction of anesthesia and positioning of patients in lithotomy position.</description>
    <arm_group_label>Aminophylline group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>Patients will receive 100 ml normal saline over 20 minutes after induction and lithotomy positioning.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged between 18 to 50 years&#xD;
&#xD;
          -  American society of anesthesiology (ASA) physical status I - II&#xD;
&#xD;
          -  Body mass index (BMI) less than 30.0 kg/m2&#xD;
&#xD;
          -  Scheduled for ureteroscopic lithotripsy surgery with D-J ureteric stent placement at&#xD;
             the end of procedure&#xD;
&#xD;
          -  Under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with central nervous system diseases, cardiovascular diseases, arrhythmias,&#xD;
             cerebrovascular diseases, convulsions, renal impairment or hepatic dysfunction.&#xD;
&#xD;
          2. Pregnancy or lactation.&#xD;
&#xD;
          3. Patients with a history of allergy to aminophylline.&#xD;
&#xD;
          4. Coffee consumption (more than 2 cups/day)&#xD;
&#xD;
          5. Patients with opioid addiction or patients treated with B agonists, tranquilizers, or&#xD;
             antidepressants.&#xD;
&#xD;
          6. Short procedures less than 30 minutes or procedures not requiring D-J stent placement.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tanta University Hospitals</name>
      <address>
        <city>Tanta</city>
        <state>ElGharbiaa</state>
        <zip>31527</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama M Rehab, MD</last_name>
      <phone>00201095210806</phone>
      <email>osamarehab@med.tanta.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>January 21, 2023</study_first_submitted>
  <study_first_submitted_qc>January 21, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2023</study_first_posted>
  <last_update_submitted>March 5, 2023</last_update_submitted>
  <last_update_submitted_qc>March 5, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Osama Rehab</investigator_full_name>
    <investigator_title>Lecturer of Anesthesiology, Intensive Care and Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>Aminophylline</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Ureterocopic Lithotripsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aminophylline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be available upon a reasonable request from the corresponding author</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>The data will be available 6 months after publication</ipd_time_frame>
    <ipd_access_criteria>The data will be available upon a reasonable request from the corresponding author</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

